OTLK Outlook Therapeutics, Inc.
Oncobiologics Inc is a clinical-stage biopharmaceutical company. It is engaged in identifying, developing, manufacturing and commercializing complex biosimilar therapeutics in the disease areas of immunology and oncology.
$2.20 +0.05 (2.09%)
As of 03/02/2021 15:59:11 EST IEX book CBOE book
Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Small cap
Health Care
Biotechnology
USA
06/14/2016
173,432,010
11,577,125
$372,878,822
0.00%
SEC Edgar Online
10-Q
10-K
69012T107
Common stocks
Small cap
Health Care
Biotechnology
USA
06/14/2016
173,432,010
11,577,125
$372,878,822
0.00%
SEC Edgar Online
10-Q
10-K
69012T107
Valuation (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
PB ratio:
PS ratio:
Return on equity:
Net income %:
0.00
97.73
0.00
315.92%
0.00%
97.73
0.00
315.92%
0.00%